Phytochemical Profiling and Pharmacological Activities of <i>Abutilon ramosum</i> in Chronic Disease Management: A Comprehensive Review

Background: Chronic diseases like diabetes, inflammation, arthritis, and gastrointestinal disorders are globally significant health issues that generate growing interest towards alternative multi-targeted therapeutic options such as phytotherapeutic approaches. Aim: This review focuses on the botany, phytochemistry, and pharmacological potential of Abutilon ramosum with a comprehensive comparative discussion with A. indicum. Methods: The present work is an illustrative review based on literature concerning the phytochemical composition and pharmacological activities of A. ramosum , along with its ethanomedicinal significance and comparison with closely related species. Results: Abutilon ramosum ( Malvaceae ) is an ethnomedicinal shrub indigenous to Africa and Asia, that harbours bioactive compounds including quercetin, luteolin, gallic and ferulic acids as well as glycosides, and polysaccharides. Their constituents support their traditional use for inflammatory and metabolic disorders. Preclinical studies show its anti-inflammatory, antioxidant, anti-diabetic, anti-arthritic, and gastroprotective activities through modulation of cytokines, oxidative stress, and metabolic pathways. Conclusion: Although A. ramosum shows promising multi-target therapeutic potential compared to synthetic drugs, there is a lack of species-specific clinical studies. Future research should focus on bioassay-guided isolation, network pharmacology approaches, advanced in vivo studies, and clinical trials for the development of standardised extracts in the management of chronic diseases. Major Findings: Abutilon ramosum exhibits significant multi-target pharmacological activities due to its rich phytochemical profile. It shows potential in managing chronic diseases such as inflammation, diabetes, and arthritis. However, clinical validation is still required.

View article page

Download PDF